Prostate cancer prevention strategies using antiproliferative or differentiating agents.

This publication has 21 references indexed in Scilit:

• Effects of methylacetylenic putrescine, an ornithine decarboxylase inhibitor and potential novel anticancer agent, on human and mouse cancer cell lines
  Anti-Cancer Drugs, 1999
• Induction of apoptosis in prostate cancer cell lines by the green tea component, (−)-epigallocatechin-3-gallate
  Cancer Letters, 1998
• Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden)
  Cancer Causes & Control, 1998
• Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: A hypothesis
  Cancer Causes & Control, 1998
• Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma Cells
  JNCI Journal of the National Cancer Institute, 1997
• Vitamin d inhibition of prostate adenocarcinoma growth and metastasis in the dunning rat prostate model system
  Urology, 1997
• 1,25-dihydroxy-16-ene-23-yne-vitamin d3 and prostate cancer cell proliferation in vivo
  Urology, 1995
• Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.
  Endocrinology, 1993
• Imaging prostate derived tumors with PET and N-(3-[18F]fluoropropyl)putrescine
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1990
• Copenhagen rat prostatic tumor ornithine decarboxylase activity (ODC) and the effect of the ODC inhibitor alpha-difluoromethylornithine
  The Prostate, 1982